| __timestamp | Cytokinetics, Incorporated | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 2983000000 |
| Thursday, January 1, 2015 | 19667000 | 3426000000 |
| Friday, January 1, 2016 | 27823000 | 3398000000 |
| Sunday, January 1, 2017 | 36468000 | 3878000000 |
| Monday, January 1, 2018 | 31282000 | 4056000000 |
| Tuesday, January 1, 2019 | 39610000 | 4381000000 |
| Wednesday, January 1, 2020 | 52820000 | 5151000000 |
| Friday, January 1, 2021 | 96803000 | 5246000000 |
| Saturday, January 1, 2022 | 177977000 | 5673000000 |
| Sunday, January 1, 2023 | 173612000 | 6090000000 |
| Monday, January 1, 2024 | 6091000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, operational efficiency is key. Over the past decade, Gilead Sciences, Inc. and Cytokinetics, Incorporated have demonstrated contrasting trends in their Selling, General, and Administrative (SG&A) expenses. Gilead Sciences, a giant in the biotech sector, has consistently maintained high SG&A expenses, peaking at approximately $6.1 billion in 2023, reflecting a 104% increase since 2014. This trend underscores Gilead's expansive operational scale and market reach.
Conversely, Cytokinetics, a smaller player, has shown a more dynamic growth in SG&A expenses, surging by over 900% from 2014 to 2023. This sharp rise, culminating in $178 million in 2022, highlights Cytokinetics' aggressive investment in market expansion and operational capabilities. These insights reveal the strategic priorities of both companies, offering a window into their competitive positioning in the pharmaceutical landscape.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Pharming Group N.V.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Alkermes plc
Gilead Sciences, Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Gilead Sciences, Inc. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Cytokinetics, Incorporated
Selling, General, and Administrative Costs: Incyte Corporation vs Cytokinetics, Incorporated
Madrigal Pharmaceuticals, Inc. and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Cytokinetics, Incorporated vs Alpine Immune Sciences, Inc.
Cytokinetics, Incorporated vs Merus N.V.: SG&A Expense Trends
Breaking Down SG&A Expenses: Cytokinetics, Incorporated vs MorphoSys AG
Cytokinetics, Incorporated or Dynavax Technologies Corporation: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Ligand Pharmaceuticals Incorporated